Testosterone clinical trials
Also written Androgel, Testim, LY900011 and Natesto.
Includes 53 studies of Testosterone undecanoate, 27 studies of Testosterone 17 beta-cypionate and 20 studies of Testosterone enanthate.
How each study uses Testosterone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Testosterone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 24 Dec 1953 · DELATESTRYL · NDA 009165 (FDA, Drugs@FDA; as testosterone enanthate)
- European Union
- 28 Jul 2006 · Livensa · EMEA/H/C/000630 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
331 studies that test it; most in 2006 (23); 2 more planned to start later
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 9 |
| 2003 | 6 |
| 2004 | 14 |
| 2005 | 13 |
| 2006 | 23 |
| 2007 | 21 |
| 2008 | 17 |
| 2009 | 18 |
| 2010 | 13 |
| 2011 | 13 |
| 2012 | 17 |
| 2013 | 18 |
| 2014 | 9 |
| 2015 | 16 |
| 2016 | 17 |
| 2017 | 14 |
| 2018 | 7 |
| 2019 | 9 |
| 2020 | 14 |
| 2021 | 14 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 11 |
| 2025 | 8 |
| 2026 | 8 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 90 · Other 246
Clarus Therapeutics, Inc. (11) · VA Office of Research and Development (9) · Massachusetts General Hospital (9) · University of Washington (9) · Warner Chilcott (9) · Gulhane School of Medicine (8) · Eli Lilly and Company (8) · Brigham and Women's Hospital (7)
Often tested with
Tested in the same studies.
Anastrozole (11) · Estradiol (8) · Goserelin (6) · Estrogens (4) · Dutasteride (4) · Leuprolide (3) · Progesterone (3) · Segesterone acetate (3)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Testosterone is the comparator. A study of two new drugs counts under both.
- 1Anastrozole · Georgios Papadakis · next primary completion Apr 2027
- 1Semaglutide · Georgios Papadakis · next primary completion Apr 2027
- 1Chorionic Gonadotropin · Georgios Papadakis · next primary completion Apr 2027
Reaching primary completion within a year · 13, 1 in phase 3
Studies that test Testosterone, phase 3 first.
- Mar 2027Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismPhase 3 · Amneal Pharmaceuticals, LLC
- Nov 2026Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen DeficiencyPhase 2 · Seattle Institute for Biomedical and Clinical Research
- Nov 2026Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of LifeEarly Phase 1 · Jules Bordet Institute
- Dec 2026The Anabolic Effect of Testosterone on Pelvic Floor MusclesPhase 2 · Brigham and Women's Hospital
- Dec 2026The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in HumansNot applicable · University of British Columbia
- Dec 2026Working Out M0 Bipolar Androgen TherapyPhase 2 · Australian and New Zealand Urogenital and Prostate Cancer Trials Group
- Jan 2027Testosterone Replacement in Male Cancer Survivors With Fatigue and Low TestosteronePhase 2 · Seattle Institute for Biomedical and Clinical Research
- Jun 2027Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal MenPhase 4 · Azurity Pharmaceuticals
- Aug 2027Adaptions and Resiliency to Multi-Stressor OpeRationsPhase 4 · Bradley Nindl
- Aug 2027High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate CancersPhase 2 · VA Office of Research and Development
Studies
Open first, then newest update. How each study uses Testosterone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 336
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentRecruitingPhase 2QuantumLeap Healthcare CollaborativeNCT06075953Written as Testosterone + Anastrazole
- High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate CancersRecruitingPhase 2VA Office of Research and DevelopmentNCT05011383Written as High dose testosterone
- 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With HypogonadismRecruitingPhase 3Halozyme TherapeuticsNCT06689085Written as Testosterone enanthate
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active SurveillanceRecruitingPhase 4University of MiamiNCT07278362Written as Testosterone cypionate
- Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismRecruitingPhase 3Amneal Pharmaceuticals, LLCNCT07898072Written as Testosterone Cypionate 75 mg
- A Dose Ranging Study to Examine TDS-Testosterone 5%Not yet recruitingPhase 2Transdermal Delivery Solutions CorpNCT01894308Written as Testosterone
- Adaptions and Resiliency to Multi-Stressor OpeRationsRecruitingPhase 4Bradley NindlNCT06455969Written as Testosterone gel (AndroGel 5g)
- Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI TrialNot yet recruitingPhase 2/3VA Office of Research and DevelopmentNCT07742553Written as testosterone cypionate
- Pain Alleviation With Testosterone in Opioid-Induced HypogonadismRecruitingPhase 2Brigham and Women's HospitalNCT04798469Written as Testosterone Undecanoate 250 MG/ML
- Testosterone Replacement in Male Cancer Survivors With Fatigue and Low TestosteroneRecruitingPhase 2Seattle Institute for Biomedical and Clinical ResearchNCT04049331Written as Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]
- Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active SurveillanceRecruitingPhase 4Roswell Park Cancer InstituteNCT06733350Written as Therapeutic Testosterone
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNot applicableEnhanced Emirates LimitedNCT07568574Written as Testosterone Enanthate
- Effect of Testosterone on Elderly Frail Men With Testosterone DeficiencyNot yet recruitingPhase 2Rune Skovgaard RasmussenNCT07512323Written as Nebido (Testosterone Undecanoate)
- Testosterone Treatment in Men With Chronic Kidney DiseaseRecruitingPhase 2St. Louis UniversityNCT05249634Written as Jatenzo Pill
- Working Out M0 Bipolar Androgen TherapyRecruitingPhase 2Australian and New Zealand Urogenital and Prostate Cancer Trials GroupNCT06594926Written as Testosterone Enanthate
- Bipolar Androgen Therapy + Carboplatin in mCRPCRecruitingPhase 2St Vincent's Hospital, SydneyNCT03522064Written as Testosterone Enanthate 100 MG/ML Injectable Solution
- Supraphysiologic Testosterone Priming Induces Darolutamide Extended ResponseRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07142551Written as Testosterone cypionate
- COMPASS - COpenhagen MenoPAuSe StudyRecruitingPhase 2Martin Blomberg JensenNCT07254429Written as Testosterone
- Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of LifeRecruitingEarly Phase 1Jules Bordet InstituteNCT07143279Written as Sustanon 250
- The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in HumansNot yet recruitingNot applicableUniversity of British ColumbiaNCT07212712Written as Testosterone
See all 336 studies that test Testosterone →
Given beside what is tested · 30 — Testosterone is usual care or a partner of the new treatment
- The COSMYC Trial (COmbined Suppression of MYC)RecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06922318Written as Testosterone cypionate
- Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerNot yet recruitingPhase 2/3ECOG-ACRIN Cancer Research GroupNCT07852195Written as Testosterone Cypionate
- Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPCRecruitingPhase 2Yale UniversityNCT06100705Written as Testosterone Cypionate
- Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA StudyRecruitingPhase 2University of WashingtonNCT06039371Written as Testosterone Cypionate
- Sequential Testosterone and Enzalutamide Prevents Unfavorable ProgressionRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT04363164Written as Testosterone cypionate
- Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPCRecruitingPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT07476001Written as Testosterone cypionate (Tc)
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerRecruitingPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06059118Written as testosterone cypionate
- Study to Compare DITEST to Testosterone Undecanoate in Adult Men With HypogonadismCompletedPhase 1Neurocrine UK LimitedNCT02966652Written as Testosterone undecanoate
- Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate CancerCompletedPhase 2University of WashingtonNCT03516812Written as Testosterone Enanthate
- Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This DiseaseActive, not recruitingPhase 2City of Hope Medical CenterNCT00080756Written as therapeutic testosterone
- COMbination of Bipolar Androgen Therapy and NivolumabCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT03554317Written as Testosterone cypionate
- Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate CancerCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00587431Written as Testosterone Gel
- Testosterone Plus Finasteride Treatment After Spinal Cord InjuryTerminatedPhase 2VA Office of Research and DevelopmentNCT02248701Written as Testosterone Enanthate
- RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)CompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT02090114Written as Testosterone cypionate
- Xiaflex® Plus Testosterone Treatment Pilot Study ProtocolCompletedPhase 4Men's Health BostonNCT03815331Written as Aveed
- Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in TransmenCompletedPhase 3Unita Complessa di Ostetricia e GinecologiaNCT04545450Written as Testosterone Undecanoate
- The Role of Follicle Stimulating Hormone in Advanced Prostate CancerCompletedNot applicableLund UniversityNCT04134130Written as Testosterone Undecanoate
- ITT-5 Mechanisms of Spermatogenesis in ManWithdrawnPhase 2University of WashingtonNCT02147964Written as Testosterone 1% Gel
- T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone InsulinCompletedPhase 1/2University of WashingtonNCT01686828Written as Testosterone 1.62% gel
- Influence of Administration Route of Testosterone on Male FertilityWithdrawnPhase 1Acerus Pharmaceuticals CorporationNCT00705796Written as MPP10, testosterone
Showing 20 of 30.
As the comparator · 17 — what is tested is compared with Testosterone
- Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter SyndromeRecruitingPhase 3Georgios PapadakisNCT05586802Written as Testosterone gel
- The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and ObesityCompletedPhase 3University Medical Centre LjubljanaNCT06489457Written as Testosterone Undecanoate
- Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal MenCompletedPhase 3Marius PharmaceuticalsNCT03198728Written as AndroGel
- Influence of Administration Route of Testosterone on Male FertilityWithdrawnPhase 1Acerus Pharmaceuticals CorporationNCT00705796Written as MPP10, testosterone
- Testosterone for Treating Cachexia in Patients With Squamous Cell CarcinomaCompletedPhase 1The University of Texas Medical Branch, GalvestonNCT00878995Written as Testosterone Enanthate 100 MG/ML
- Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or HypogonadismCompletedPhase 3Lipocine Inc.NCT02081300Written as Oral testosterone undecanoate, LPCN 1021
- Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)CompletedPhase 1Merck Sharp & Dohme LLCNCT01017458Written as Comparator: testosterone enanthate
- The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)CompletedPhase 2Repros Therapeutics Inc.NCT01386606Written as Testosterone
- To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical TestosteroneCompletedPhase 2Repros Therapeutics Inc.NCT00706719Written as Testim 1%
- A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%CompletedPhase 3Repros Therapeutics Inc.NCT01993225Written as AndroGel 1.62%
- A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%CompletedPhase 3Repros Therapeutics Inc.NCT01993212Written as AndroGel 1.62%
- Normalization of Morning Testosterone Levels in Men With Secondary HypogonadismCompletedPhase 2Repros Therapeutics Inc.NCT01270841Written as topical testosterone
- Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting ConditionsCompletedPhase 3Amneal Pharmaceuticals, LLCNCT02110368Written as AndroGel (testosterone gel) 1.62% Metered-Dose Pump
- Influence of Male Hormones on Regional Fat MetabolismCompletedPhase 1Mayo ClinicNCT01160328Written as Testosterone
- A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203CompletedPhase 2Repros Therapeutics Inc.NCT01386567Written as Testim (topical testosterone)
- Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary HypogonadismCompletedPhase 3Repros Therapeutics Inc.NCT00962637Written as AndroGel
- Odense Androgen Study - The Effect of Testim and Training in Hypogonadal MenStatus unknownPhase 4Odense University HospitalNCT00700024Written as Testim
What changed recently
From the registry's own updates since Oct 19, 2026.
Started recruiting1
Newly registered1
- Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismOct 27, 2026NCT07898072
Codes
What other systems call Testosterone · ClinicalTrials.gg INT008289
- MeSH (NLM) D013739TestosteroneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3XMK78S47OTESTOSTERONEConfirmed FDA, NLM, Wikidata
- Wikidata Q1318776testosteroneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C862Therapeutic TestosteroneConfirmed FDA, Wikidata
- DrugBank DB00624One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013739 | Testosterone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3XMK78S47O | TESTOSTERONE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q1318776 | testosterone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C862 | Therapeutic Testosterone | Confirmed FDA, Wikidata |
| DrugBank | DB00624 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.